SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Rule 8.3- Tissue Science

14 Mar 2008 16:31

Lady Margaret Ruth Elliot14 March 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) ADAM & COMPANY (NOMINEES) LIMITED FOR LADY MARGARET RUTH ELLIOT Company dealt in TISSUE SCIENCE LABORATORIES PLC Class of relevant security to which ORDINARY 10P SHARES the dealings being disclosed relate (Note 2) Date of dealing 13 MARCH 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 0 (0.00) 0 (0.00) (2) Derivatives (other than options) 0 (0.00) 0 (0.00) (3) Options and agreements to 0 (0.00) 0 (0.00) purchase/sell Total 0 (0.00) 0 (0.00) (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 465,909 £1.015 GBP (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 14 MARCH 2008 Contact name COLIN MOFFAT Telephone number 0131 777 1771 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Dec 20164:42 pmRNSBuy-back class ruling
22nd Dec 20163:05 pmRNSGrant of LTIP Awards
16th Dec 20168:02 amRNSAppointment of Joint Corporate Broker
15th Dec 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20165:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Dec 20167:00 amRNSChange in ISIN and SEDOL
2nd Dec 20168:06 amRNSAdmission to AIM and First Day of Dealings
21st Apr 20082:47 pmRNSIssue of Equity-TissueScience
8th Apr 20082:26 pmRNSTissue Science Equity Issue
2nd Apr 20084:44 pmRNSTissue Science Laboratories
2nd Apr 200812:18 pmRNSTissue Science Laboratories
1st Apr 20087:57 amRNSEPT Disclosure
28th Mar 20083:26 pmRNSHolding(s) in Company
28th Mar 200812:02 pmRNSHolding(s) in Company
28th Mar 20087:02 amRNSRule 8.1- Tissue Science Lab
27th Mar 200811:41 amRNSHolding(s) in Company
27th Mar 20089:47 amRNSRule 8.1 - Tissue Science Lab
25th Mar 20087:01 amRNSRule 8.1- Tissue Science Lab.
19th Mar 200811:29 amRNSHolding(s) in Company
19th Mar 20089:29 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:25 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:22 amRNSRule 8.1- Tissue Science Lab.
14th Mar 20084:31 pmRNSRule 8.3- Tissue Science
14th Mar 20082:21 pmRNSRule 8.3- Tissue Science
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:15 amRNSRule 8.3- Tissue Science
14th Mar 20088:09 amRNSRule 8.1- Tissue Science Lab
13th Mar 20082:26 pmBUSRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20082:05 pmRNSRule 8.1- Tissue Science Lab.
13th Mar 20081:07 pmRNSEPT Disclosure-Amend
13th Mar 200811:05 amPRNRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20088:36 amRNSEPT Disclosure
13th Mar 20087:00 amRNSRule 8.1- Tissue Science Lab.
12th Mar 20083:55 pmRNSOffer Document Posted
12th Mar 20087:01 amRNSOffer for Tissue Science Lab.
12th Mar 20087:01 amRNSFinal Results & Cash Offer
17th Jan 20087:00 amRNSPositive Study Results
12th Nov 200710:47 amRNSHolding(s) in Company
7th Nov 20074:22 pmRNSHolding(s) in Company
28th Sep 20077:02 amRNSInterim Results
10th Sep 20077:01 amRNSNotice of Results
28th Aug 200712:26 pmRNSHolding(s) in Company
17th Aug 20073:28 pmRNSAIM Rule 26 Compliance
6th Jul 20072:25 pmRNSResult of AGM
6th Jul 20077:00 amRNSPre-close Trading Statement
29th Jun 20074:00 pmRNSTotal Voting Rights
14th Jun 20077:00 amRNSNotice of AGM
31st May 200712:00 pmRNSExercising of Options
16th Apr 20077:01 amRNSR&D Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.